Eskopeo Advisors

The P-I-V Engine

A Sustainability Life-Cycle

eskopeo is built on the collective expertise of three senior partners dedicated to bridging the gap between Purpose, Impact, and Value.

1

Purpose: The Direction

Every strategy first passes a filter: Does this leverage clinical potential and follow patient demand?
2

Impact: The Proof

We measure success through tangible outcomes for patients, caregivers and healthcare professionals.
3

Value: The Fuel

Commercial impact generates value — the fuel to sustain the cycle of innovation and profitability.

"In healthcare, we shouldn't choose between doing good and doing well. The P-I-V Cycle is our roadmap: Purpose creates a measurable Impact for patients. That impact generates the economic Value necessary to follow up on our Purpose. It's a self-sustaining wheel where the patient's health and the company's health are perfectly aligned."

Value Proposition

As a CEO, you know that improving profitability and efficiency rarely comes from analysis alone. It requires people who truly understand how pharmaceutical businesses operate.

At eskopeo, you work directly with partners who combine deep pharmaceutical expertise with senior leadership experience — including CEO-level perspective within our team. We understand the realities of leading a pharmaceutical business and engage with you as peers, bringing a clear, independent focus on value creation.

Because we understand how pharmaceutical organizations work from the inside, we tailor our approach to your needs - whether that means closely involving your team or minimizing disruption to ongoing operations.

Unlock hidden value in your pharmaceutical portfolio

Our focus is straightforward: uncover and unlock hidden value within your existing portfolio. This can range from pruning underperforming products and optimizing pricing strategies to simplifying SKU complexities and redefining go-to-market models.

We typically begin with a rapid Value Driver Screening, providing you with an independent external perspective on where untapped value may exist. Based on these insights, you can decide whether to pursue a focused value-creation initiative designed to materially improve financial performance. You are in full control of the scope and approach taken at any step in our partnership.

Our Collaborative Journey

A phased approach designed to provide maximum transparency, value, and control at every step of our partnership.

01

Portfolio
Diagnostic

We begin with a thorough diagnostic of your portfolio to understand your current strategy and the positioning in your target market.

Outcome: Identification of "hidden champions," untapped potential, expansion opportunities, or candidates for pruning.

02

Portfolio
Strategy

We co-create a Portfolio Strategy based on the Phase 1 findings. We then assist you shifting focus toward the most value-adding activities.

Outcome: A strategic roadmap designed to strengthen your brand positioning and maximize financial output.

03

Go-to-Market
Model

We evolve your current market approach into a high-efficiency GTM model, bridging the gap between lean operations and maximum impact.

Outcome: Modern, lean approaches that lead to major cost savings while increasing market presence.

Even if the analysis reveals limited additional upside, the outcome remains valuable: greater clarity and confidence for your strategic decision-making.

Most pharmaceutical portfolios contain untapped value. The challenge is not identifying opportunities on paper - it is translating them into measurable financial impact. If you value an experienced external perspective on your portfolio, we will welcome the opportunity to start a conversation.